Controlled release formulations of octreotide
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 13, 2013
Grant Date -
Dec 16, 2010
app pub date -
Jun 11, 2010
filing date -
Mar 11, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully